Search

everythinglearnresearchcommunity

for

Search:↓

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

A 37-year-old male with severe skin and internal issues has a rare inherited skin condition called dystrophic epidermolysis bullosa.

Most Cochrane Skin Group reviews are helpful for improving dermatology practices, but some lack enough evidence for clinical recommendations.

Skin reactions from cancer treatments might predict how well the treatments work.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Growth hormone levels affect hair growth and loss, with too much causing excess hair and too little leading to hair loss.

People with certain allergic conditions or higher white blood cell counts have more severe hair loss, and treating hair and nail side effects early in melanoma therapy can improve quality of life.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

Nivolumab treatment led to hair regrowth in a man with metastatic melanoma and alopecia areata.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

Wnt activation shows promise for regenerative medicine but requires selective targeting to minimize risks like cancer.

scINSIGHT accurately identifies cell clusters and gene patterns in complex data.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

The document concludes that scalp conditions have various causes and can present in many different ways.

The symposium showed that stem cells are key for understanding and treating skin diseases and for developing new skin models and therapies.

Photodynamic therapy is the preferred treatment for skin precancer due to its effectiveness and safety.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

LGR5 and LGR6 are expressed differently in various skin tumors, which may offer clues about their origins.

A clinically suspected melanoma appeared benign under the microscope but was confirmed by specific tests and a rare mutation.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

New research suggests that skin cell renewal may not require a special type of cell previously thought to be essential.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Notch/CSL signaling controls hair follicle differentiation through Wnt5a and FoxN1.

Most skin tumors in the study were benign, with squamous cell carcinoma being the most common malignant type.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.